ArticleBMC cancer2023

Immune inactivation by VISTA predicts clinical outcome and therapeutic benefit in muscle-invasive bladder cancer.

Wandi Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.